Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(R)-4-(2,4-diMethoxybenzyl)-3-Methylpiperazin-2-one, also known as 2,4-dimethoxybenzyl-3-methylpiperazin-2-one, is a chemical compound with the molecular formula C16H22N2O3. It is a piperazinone derivative and a central nervous system depressant that can affect the brain and nervous system. (R)-4-(2,4-diMethoxybenzyl)-3-Methylpiperazin-2-one is characterized by its unique chemical structure, which includes a piperazin-2-one core with a 3-methyl substituent and a 2,4-dimethoxybenzyl group attached to the 4-position. Its properties and potential applications have made it a subject of interest in the field of medicinal chemistry.

1383146-20-0

Post Buying Request

1383146-20-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1383146-20-0 Usage

Uses

Used in Pharmaceutical Research and Development:
(R)-4-(2,4-diMethoxybenzyl)-3-Methylpiperazin-2-one is used as a research compound for the development of pharmaceuticals, particularly in the study of its potential as a psychoactive drug. Its unique chemical structure and central nervous system depressant properties make it a promising candidate for further investigation into its effects and potential therapeutic uses.
Used in the Study of Central Nervous System Depressants:
In the field of neuroscience, (R)-4-(2,4-diMethoxybenzyl)-3-Methylpiperazin-2-one is used as a research tool to study the effects of central nervous system depressants on the brain and nervous system. Its ability to modulate neural activity and potentially produce sedative or anxiolytic effects makes it valuable for understanding the mechanisms of action of such compounds.
Used in Medicinal Chemistry:
(R)-4-(2,4-diMethoxybenzyl)-3-Methylpiperazin-2-one is utilized in medicinal chemistry for the synthesis of novel compounds with potential therapeutic applications. Its versatile chemical structure allows for the development of derivatives with modified properties, which can be explored for their potential as new drugs or drug candidates.
Used in Drug Design and Optimization:
In the process of drug design and optimization, (R)-4-(2,4-diMethoxybenzyl)-3-Methylpiperazin-2-one serves as a starting point for the development of new pharmaceutical agents. Its unique features can be leveraged to create compounds with improved pharmacological properties, such as increased potency, selectivity, or reduced side effects.

Check Digit Verification of cas no

The CAS Registry Mumber 1383146-20-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,8,3,1,4 and 6 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1383146-20:
(9*1)+(8*3)+(7*8)+(6*3)+(5*1)+(4*4)+(3*6)+(2*2)+(1*0)=150
150 % 10 = 0
So 1383146-20-0 is a valid CAS Registry Number.

1383146-20-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (3R)-4-[(2,4-dimethoxyphenyl)methyl]-3-methylpiperazin-2-one

1.2 Other means of identification

Product number -
Other names WT1241

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1383146-20-0 SDS

1383146-20-0Relevant articles and documents

NOVEL CHIRAL N-ACYL-5,6,7,(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS AND CHIRAL SYNTHESIS THEREOF

-

Page/Page column 136-137, (2013/04/24)

The present invention relates to novel compounds of Formula I and their use in therapeutic treatments. The invention further relates to a novel chiral synthesis of 5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines using N-sp3 protective groups. The invention also provides intermediates for use in the synthesis of compounds of Formula I.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1383146-20-0